Return to homepagePandemic Pact

Genomic surveillance SARS-CoV2, preliminary phase

  • Funded by Federal Office of Public Health (FOPH)
  • Total publications:0 publications

Grant number: 48815

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $1,229,828.4

  • Funder

    Federal Office of Public Health (FOPH)

  • Principal Investigator

    Bourqui-Pittet Martine

  • Research Location

    Switzerland

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The course of the SARS-CoV-2 coronavirus pandemic is influenced by the circulating strains of the virus. Some strains can have decisive epidemiological characteristics, such as greater contagiousness, more severe disease progression, or reduced vaccine efficacy. In December 2020, strains of the so-called UK variant, or Alpha variant, began circulating, suggesting a potentially more contagious strain. It was urgent to establish a genomic surveillance system by sequencing a number of coronavirus-positive samples. ETH Zurich, through its Science Task Force and Professor Stadler, made its laboratories, resources, and expertise available for this implementation...